A recent CDC revision to the reference value used to identify children with high levels of lead in their blood doubled the estimated number of children who should be referred for follow-up, per guidelines, a pair of experts noted recently.
In a perspective published in Pediatrics, Alan D. Woolf, MD, MPH, director of the environmental medicine program at Boston Children’s Hospital, and Mary Jean Brown, ScD, RN, former chief of the CDC’s Lead Poisoning Prevention Branch, also discussed the reissue of the LeadCare II testing instrument following a recall.
We spoke with Woolf about